CoChat

A GRASP55-rab2 effector complex linking Golgi structure to membrane traffic

Open access
Short, Benjamin, Preisinger, Christian, Körner, Roman, Kopajtich, Robert, Byron, Olwyn, Barr, Francis A. · 2001 · The Journal of Cell Biology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Membrane traffic between the endoplasmic reticulum (ER) and Golgi apparatus and through the Golgi apparatus is a highly regulated process controlled by members of the rab GTPase family. The GTP form of rab1 regulates ER to Golgi transport by interaction with the vesicle tethering factor p115 and the cis-Golgi matrix protein GM130, also part of a complex with GRASP65 important for the organization of cis-Golgi cisternae. Here, we find that a novel coiled-coil protein golgin-45 interacts with the medial-Golgi matrix protein GRASP55 and the GTP form of rab2 but not other Golgi rab proteins. Depletion of golgin-45 disrupts the Golgi apparatus and causes a block in secretory protein transport. These results demonstrate that GRASP55 and golgin-45 form a rab2 effector complex on medial-Golgi essential for normal protein transport and Golgi structure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.200108079

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Golgin-45 is a novel GRASP55 interacting protein. (A) Amino acids 12–404 of golgin-45 were identified using the yeast two- hybrid system by screening GRASP55 against a human testis cDNA library. Golgin-45 and a COOH-terminal deletion mutant were tested for interaction with GRASP55 and GRASP65 in the yeast two-hybrid system compared with GM130 and empty vector as positive and negative controls, respectively. (B) Coimmunoprecipitations of in vitro–translated GRASP55 and GRASP65 with golgin-45 and GM130. (C) GRASP55 complexes were affinity purified from detergent extracts of Golgi membranes. Specifically, interacting proteins were excised (arrowheads) and tryptic digests of the proteins contained therein analyzed by mass spectrometry. (D) Golgi membranes (10 μg) were Western blotted with antibodies to golgin-45 in the presence (+) or absence (−) of 10 μg/ml of recombinant golgin-45. Control blots are also shown for the antibodies to GRASP65, GRASP55, and GM130. (E) Immunoprecipitations (IPs) were performed from 20 μg Golgi membranes with the following antibodies: sheep anti-GRASP55, mouse anti-GRASP65, sheep anti-GM130, and rabbit anti–golgin-45. Immunoprecipitates were blotted with the following antibodies: GRASP55 and GRASP65 IPs with rabbit anti-GM130 and rabbit anti–golgin-45, GM130 IPs with rabbit anti-GRASP55 and mouse anti-GRASP65, and golgin-45 IPs with sheep anti-GRASP55 and mouse anti-GRASP65. Asterisks indicate a nonspecific cross-reactivity of the rabbit anti-GRASP55 antibody to the sheep antibody used for the IP.
Figure 1. Golgin-45 is a novel GRASP55 interacting protein. (A) Amino acids 12–404 of golgin-45 were identified using the yeast two- hybrid system by screening GRASP55 against a human testis cDNA library. Golgin-45 and a COOH-terminal deletion mutant were tested for interaction with GRASP55 and GRASP65 in the yeast two-hybrid system compared with GM130 and empty vector as positive and negative controls, respectively. (B) Coimmunoprecipitations of in vitro–translated GRASP55 and GRASP65 with golgin-45 and GM130. (C) GRASP55 complexes were affinity purified from detergent extracts of Golgi membranes. Specifically, interacting proteins were excised (arrowheads) and tryptic digests of the proteins contained therein analyzed by mass spectrometry. (D) Golgi membranes (10 μg) were Western blotted with antibodies to golgin-45 in the presence (+) or absence (−) of 10 μg/ml of recombinant golgin-45. Control blots are also shown for the antibodies to GRASP65, GRASP55, and GM130. (E) Immunoprecipitations (IPs) were performed from 20 μg Golgi membranes with the following antibodies: sheep anti-GRASP55, mouse anti-GRASP65, sheep anti-GM130, and rabbit anti–golgin-45. Immunoprecipitates were blotted with the following antibodies: GRASP55 and GRASP65 IPs with rabbit anti-GM130 and rabbit anti–golgin-45, GM130 IPs with rabbit anti-GRASP55 and mouse anti-GRASP65, and golgin-45 IPs with sheep anti-GRASP55 and mouse anti-GRASP65. Asterisks indicate a nonspecific cross-reactivity of the rabbit anti-GRASP55 antibody to the sheep antibody used for the IP.CC BY-NC-SA · PubMed Central
Figure 2. Golgin-45 is a specific binding partner for activated rab2, whereas GM130 binds both rab1 and 2. (A) Rab1, 2, and 6 beads loaded with either GDP or GTPγS were incubated with Golgi extract and the specifically eluted proteins analyzed by Western blotting. Note that golgin-45 is depleted from the supernatant of rab2-GTP beads. (B) Full-length golgin-45 and p115 were tested for interaction with wild-type rab2 and the following rab proteins carrying activating point mutations rab1Q70L, rab2Q65L, rab5Q79L, and rab6Q72L. (C) Full-length and truncation mutants of golgin-45 were tested for interaction with rab2Q65L and GRASP55 in the yeast two-hybrid system. Interaction was scored by assessing growth on QDO plates, from none (−) to strong (+++).
Figure 2. Golgin-45 is a specific binding partner for activated rab2, whereas GM130 binds both rab1 and 2. (A) Rab1, 2, and 6 beads loaded with either GDP or GTPγS were incubated with Golgi extract and the specifically eluted proteins analyzed by Western blotting. Note that golgin-45 is depleted from the supernatant of rab2-GTP beads. (B) Full-length golgin-45 and p115 were tested for interaction with wild-type rab2 and the following rab proteins carrying activating point mutations rab1Q70L, rab2Q65L, rab5Q79L, and rab6Q72L. (C) Full-length and truncation mutants of golgin-45 were tested for interaction with rab2Q65L and GRASP55 in the yeast two-hybrid system. Interaction was scored by assessing growth on QDO plates, from none (−) to strong (+++).CC BY-NC-SA · PubMed Central
Figure 3. Golgin-45 behaves like a Golgi matrix protein upon BFA treatment. (A) Normal rat kidney (NRK) cells were fixed and then stained with antibodies to golgin-45 and GRASP55. In the merged images, DNA is blue, golgin-45 is indicated in red, GRASP55 in green, with yellow indicating areas of golgin-45 and GRASP55 overlap. (B) NRK cells were treated with 5 μg/ml BFA or 200 ng/ml nocodazole for 30 and 60 min, respectively, before fixation and antibody staining. (C) NRK cells were transfected with GFP–golgin-45 for 12 h and then fixed and stained with antibodies to GRASP55. Bar, 10 μm.
Figure 3. Golgin-45 behaves like a Golgi matrix protein upon BFA treatment. (A) Normal rat kidney (NRK) cells were fixed and then stained with antibodies to golgin-45 and GRASP55. In the merged images, DNA is blue, golgin-45 is indicated in red, GRASP55 in green, with yellow indicating areas of golgin-45 and GRASP55 overlap. (B) NRK cells were treated with 5 μg/ml BFA or 200 ng/ml nocodazole for 30 and 60 min, respectively, before fixation and antibody staining. (C) NRK cells were transfected with GFP–golgin-45 for 12 h and then fixed and stained with antibodies to GRASP55. Bar, 10 μm.CC BY-NC-SA · PubMed Central
Figure 4. Depletion of golgin-45 disrupts the Golgi apparatus. (A) HeLa cells were treated with duplex RNA to target golgin-45 for 36 h and then transfected for a further 18 h with a plasmid encoding GFP-tagged n-acetylglucosaminyltransferase-I before fixation and staining with antibodies to golgin-45. (B and C) HeLa cells were treated with RNA duplexes to target golgin-45 for 48 h before fixation and staining with antibodies to golgin-45, GRASP55, and GM130. Bars, 10 μm.
Figure 4. Depletion of golgin-45 disrupts the Golgi apparatus. (A) HeLa cells were treated with duplex RNA to target golgin-45 for 36 h and then transfected for a further 18 h with a plasmid encoding GFP-tagged n-acetylglucosaminyltransferase-I before fixation and staining with antibodies to golgin-45. (B and C) HeLa cells were treated with RNA duplexes to target golgin-45 for 48 h before fixation and staining with antibodies to golgin-45, GRASP55, and GM130. Bars, 10 μm.CC BY-NC-SA · PubMed Central
Figure 5. Depletion of golgin-45 disrupts transport of VSV-G protein from the ER to the cell surface. Control (A) or golgin-45 (B) RNAi cells were transfected with a plasmid encoding GFP-tagged VSV-G ts045 protein. VSV-G ts045was arrested in the ER at 39.5°C and then chased out at 31.5°C for 30 and 60 min. Images are shown of cells fixed after 0, 30, and 60 min of chase for both total and cell surface–associated VSV-G. (C) The extent of VSV-G transport after 0, 30, and 60 min chase at 31.5°C was measured in control and golgin-45–depleted cells. This ratio does not approach unity due to the different dyes used to measure surface and total fluorescence. The data shown is representative of three experiments with n = 20 for all data points in each experiment. Live cell videos showing VSV-G ts045 transport in control and golgin-45 depleted cells are available at http://www.jcb.org/cgi/content/full/jcb.200108079/DC1. Bars, 20 μm.
Figure 5. Depletion of golgin-45 disrupts transport of VSV-G protein from the ER to the cell surface. Control (A) or golgin-45 (B) RNAi cells were transfected with a plasmid encoding GFP-tagged VSV-G ts045 protein. VSV-G ts045was arrested in the ER at 39.5°C and then chased out at 31.5°C for 30 and 60 min. Images are shown of cells fixed after 0, 30, and 60 min of chase for both total and cell surface–associated VSV-G. (C) The extent of VSV-G transport after 0, 30, and 60 min chase at 31.5°C was measured in control and golgin-45–depleted cells. This ratio does not approach unity due to the different dyes used to measure surface and total fluorescence. The data shown is representative of three experiments with n = 20 for all data points in each experiment. Live cell videos showing VSV-G ts045 transport in control and golgin-45 depleted cells are available at http://www.jcb.org/cgi/content/full/jcb.200108079/DC1. Bars, 20 μm.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. 1993, Mol. Biol. Cell., 7, 679

Cited by

See all 228

Metadata

Authors
Short, B., Preisinger, C., Körner, R., Kopajtich, R., Byron, O., & Barr, F. A.
Affiliations
  • Max Planck Institute of Biochemistry (DE)
  • 1Department of Cell Biology, Max-Planck-Institute of Biochemistry, Martinsried D-82152, Germany
  • University of Glasgow (GB)
Venue
The Journal of Cell Biology
Published
2001-12-10
Volume
155
Issue
6
Pages
877-884
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2136773542
Cited by
226
References
31
Citations by year
2026: 3 · 2025: 6 · 2024: 10 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 8 · 2019: 11 · 2018: 6 · 2017: 11 · 2016: 8 · 2015: 9 · 2014: 11 · 2013: 8 · 2012: 6
FWCI
4.77
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Cell Biology (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders
Wellcome Trust
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
Keywords
GRASP55, Rab2, Golgi apparatus structure, membrane traffic, secretory protein transport, ER-Golgi transport, Golgi organization
MeSH terms
Golgi Matrix Proteins, Animals, Autoantigens, Golgi Apparatus, HeLa Cells, Humans, Kidney, Membrane Proteins, Molecular Sequence Data, Yeasts, rab2 GTP-Binding Protein, Two-Hybrid System Techniques, Protein Transport, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A GRASP55-rab2 effector complex linking Golgi structure to membrane traffic. https://app.cochat.ai/papers/10.1083/jcb.200108079
The paper
Short, B., Preisinger, C., Körner, R., Kopajtich, R., Byron, O., & Barr, F. A. (2001). A GRASP55-rab2 effector complex linking Golgi structure to membrane traffic. The Journal of Cell Biology. https://doi.org/10.1083/jcb.200108079

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.